Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sharrack

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Biochemical Society Transactions|July 20, 2007
Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the ratG Haddock, A K Cross, S Allan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2014
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trialA Carter, A Daley, L Humphreys, et al.
Bone Marrow Transplantation|November 21, 2019
Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)P Tappenden, Y Wang, B Sharrack, et al.
Acta Neurologica Scandinavica|October 16, 2008
PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unitM Hadjivassiliou, S J Alder, E J R Van Beek, et al.
Lancet (London, England)|June 24, 2008
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb studyG Comi, A Pulizzi, M Rovaris, et al.
Neuroscience|February 28, 2016
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryoA Seytanoglu, N I Alsomali, C F Valori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2006
Neuropathy associated with gluten sensitivityM Hadjivassiliou, R A Grünewald, R H Kandler, et al.
Neurology|July 13, 2006
Clinical features of hereditary spastic paraplegia due to spastin mutationC J McDermott, C E Burness, J Kirby, et al.
Bone Marrow Transplantation|October 27, 2009
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysisP Tappenden, R Saccardi, C Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosisJ Das, J A Snowden, J Burman, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Biochemical Society Transactions|July 20, 2007
Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the ratG Haddock, A K Cross, S Allan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2014
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trialA Carter, A Daley, L Humphreys, et al.
Bone Marrow Transplantation|November 21, 2019
Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)P Tappenden, Y Wang, B Sharrack, et al.
Acta Neurologica Scandinavica|October 16, 2008
PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unitM Hadjivassiliou, S J Alder, E J R Van Beek, et al.
Lancet (London, England)|June 24, 2008
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb studyG Comi, A Pulizzi, M Rovaris, et al.
Neuroscience|February 28, 2016
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryoA Seytanoglu, N I Alsomali, C F Valori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2006
Neuropathy associated with gluten sensitivityM Hadjivassiliou, R A Grünewald, R H Kandler, et al.
Neurology|July 13, 2006
Clinical features of hereditary spastic paraplegia due to spastin mutationC J McDermott, C E Burness, J Kirby, et al.
Bone Marrow Transplantation|October 27, 2009
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysisP Tappenden, R Saccardi, C Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosisJ Das, J A Snowden, J Burman, et al.
Pageof 5